Brii Biosciences (02137) Announces 613,412-Share Increase in October 2025

Bulletin Express

Nov 05

Brii Biosciences Limited (02137) reported that its authorized share capital remained unchanged at 1,200,000,000 ordinary shares, with a par value of USD 0.000005 per share, equivalent to an authorized capital of USD 6,000 as of October 31, 2025.

The total number of issued shares (excluding treasury shares) rose from 720,323,173 to 720,936,585, while the number of treasury shares remained at 12,723,500. As a result, the overall issued share count increased by 613,412 shares, from 733,046,673 to 733,660,085.

According to disclosures, 442,500 new shares were issued under various share option schemes, generating HKD 153,213.65, and 170,912 new shares were issued through share award schemes. There were no movements in treasury shares during the period. The company confirmed that all issuance procedures comply with relevant rules, laws, and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1123264337"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123264337\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123264337?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123264337","market":"us","top_or_hot":-1,"title":"Brii Biosciences (02137) Announces 613,412-Share Increase in October 2025","media":"Bulletin Express","content":"<p>Brii Biosciences Limited (02137) reported that its authorized share capital remained unchanged at 1,200,000,000 ordinary shares, with a par value of USD 0.000005 per share, equivalent to an authorized capital of USD 6,000 as of October 31, 2025.</p>\n<p>The total number of issued shares (excluding treasury shares) rose from 720,323,173 to 720,936,585, while the number of treasury shares remained at 12,723,500. As a result, the overall issued share count increased by 613,412 shares, from 733,046,673 to 733,660,085.</p>\n<p>According to disclosures, 442,500 new shares were issued under various share option schemes, generating HKD 153,213.65, and 170,912 new shares were issued through share award schemes. There were no movements in treasury shares during the period. The company confirmed that all issuance procedures comply with relevant rules, laws, and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brii Biosciences (02137) Announces 613,412-Share Increase in October 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrii Biosciences (02137) Announces 613,412-Share Increase in October 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 17:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Brii Biosciences Limited (02137) reported that its authorized share capital remained unchanged at 1,200,000,000 ordinary shares, with a par value of USD 0.000005 per share, equivalent to an authorized capital of USD 6,000 as of October 31, 2025.</p>\n<p>The total number of issued shares (excluding treasury shares) rose from 720,323,173 to 720,936,585, while the number of treasury shares remained at 12,723,500. As a result, the overall issued share count increased by 613,412 shares, from 733,046,673 to 733,660,085.</p>\n<p>According to disclosures, 442,500 new shares were issued under various share option schemes, generating HKD 153,213.65, and 170,912 new shares were issued through share award schemes. There were no movements in treasury shares during the period. The company confirmed that all issuance procedures comply with relevant rules, laws, and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02137","symbol_name":"腾盛博药-B","start_time":0,"source_url":"","article_id":"1123264337","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123264337","pubTimestamp":1762335857,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Brii Biosciences Limited (02137) reported that its authorized share capital remained unchanged at 1,200,000,000 ordinary shares, with a par value of USD 0.000005 per share, equivalent to an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02137":"腾盛博药-B"},"translate_title":"布瑞生物(02137)公布2025年10月增持613,412股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02137":1},"content_text":"Brii Biosciences Limited (02137) reported that its authorized share capital remained unchanged at 1,200,000,000 ordinary shares, with a par value of USD 0.000005 per share, equivalent to an authorized capital of USD 6,000 as of October 31, 2025.\nThe total number of issued shares (excluding treasury shares) rose from 720,323,173 to 720,936,585, while the number of treasury shares remained at 12,723,500. As a result, the overall issued share count increased by 613,412 shares, from 733,046,673 to 733,660,085.\nAccording to disclosures, 442,500 new shares were issued under various share option schemes, generating HKD 153,213.65, and 170,912 new shares were issued through share award schemes. There were no movements in treasury shares during the period. The company confirmed that all issuance procedures comply with relevant rules, laws, and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}